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Abstract
Objectives: To test the inter-rater reliability of the RoB tool applied to Physical Therapy (PT) trials by comparing ratings from
Cochrane review authors with those of blinded external reviewers.
Methods: Randomized controlled trials (RCTs) in PT were identified by searching the Cochrane Database of Systematic
Reviews for meta-analysis of PT interventions. RoB assessments were conducted independently by 2 reviewers blinded to
the RoB ratings reported in the Cochrane reviews. Data on RoB assessments from Cochrane reviews and other
characteristics of reviews and trials were extracted. Consensus assessments between the two reviewers were then
compared with the RoB ratings from the Cochrane reviews. Agreement between Cochrane and blinded external reviewers
was assessed using weighted kappa (k).
Results: In total, 109 trials included in 17 Cochrane reviews were assessed. Inter-rater reliability on the overall RoB
assessment between Cochrane review authors and blinded external reviewers was poor (k = 0.02, 95%CI: 20.06, 0.06]).
Inter-rater reliability on individual domains of the RoB tool was poor (median k = 0.19), ranging from k = 20.04 (‘‘Other
bias’’) to k = 0.62 (‘‘Sequence generation’’). There was also no agreement (k = 20.29, 95%CI: 20.81, 0.35]) in the overall
RoB assessment at the meta-analysis level.
Conclusions: Risk of bias assessments of RCTs using the RoB tool are not consistent across different research groups. Poor
agreement was not only demonstrated at the trial level but also at the meta-analysis level. Results have implications for
decision making since different recommendations can be reached depending on the group analyzing the evidence.
Improved guidelines to consistently apply the RoB tool and revisions to the tool for different health areas are needed.
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Introduction
The term ‘‘quality assessment’’ has been used extensively in the
literature, particularly in the context of systematic reviews, to refer
to the critical appraisal of primary studies. Different approaches to
quality assessment have been proposed for assessing the quality of
studies [1,2]. A variety of methods (scales and checklists) have been
used by different Cochrane Review groups [3,4]; however,
because of methodological inconsistencies across quality instru-
ments and the lack of empirical evidence supporting their validity
and reliability [5,6], the use of these methods was explicitly
discouraged in Cochrane reviews [3].
In 2008, the Cochrane Collaboration (CC) initiated a shift in
the approach to the evaluation of trial quality by linking the
concept of quality to the internal validity of a study (risk of bias; the
extent to which the design and conduct of a study are likely to
prevent bias) [3]. The Cochrane Collaboration developed the Risk
of Bias tool (RoB) as a method to assess risk of bias based on study
design and conduct rather than relying on general reporting issues
of trial characteristics [3]. Since then, the Cochrane Collaboration
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has required the use of the RoB tool to establish consistency in the
assessment of study quality across Cochrane Review groups.
The RoB tool is based on six domains and 7 items: sequence
generation, allocation concealment, blinding, incomplete outcome
data, selective outcome reporting, and ‘‘other sources of bias.’’
Critical assessments of the risk of bias (high, low, unclear) in each
domain are made separately for each outcome in a given study.
The choice of these components for inclusion in the tool was based
on empirical evidence of their association with effect estimates
[5,7,8]; Recent research [9,10] recommends further testing of the
psychometric properties (i.e., validity, reliability, and responsive-
ness) of the RoB tool, and evaluations of the tool in a broad range
of research fields. In addition, researchers have called for the use of
clear and consistent guidelines and classification systems to apply
and interpret the RoB tool [11]. This information is essential since
differences in the appraisal and interpretation of risk of bias across
trials can explain variation in the interpretation of results of studies
included in a systematic review, and ultimately impact the
conclusions and clinical practice.
Despite the RoB tool being increasingly used in Cochrane
reviews; few studies have assessed its psychometric properties,
specifically in paediatric trials, general medical and oncology trials
[9,10,12,13]. Ihe inter-rater agreement for the individual domains
of the RoB tool has been found to range from poor (k [kappa] =
0.13 for selective reporting) to substantial (k = 0.74 for sequence
generation) [9]. A recent study [13] assessed the reliability of the
RoB tool between individual reviewers and across consensus
ratings of pairs of reviewers on a sample of 154 and 30 randomized
clinical trials (RCTs) published in the general medical literature
respectively. The study found that the reliability between pairs of
reviewers was ‘‘fair’’ for most of RoB domains with kappa values
ranging from 0.2 to 0.34. However, the agreement between
consensus ratings was always poorer than the agreement between
pairs of reviewers indicating a high variability in interpreting and
applying the RoB tool across different systematic review groups
and across systematic reviews [13]. This agreement in consensus
ratings (across pair of reviewers) was conducted only on 30 trials
within a group of reviewers from the same team using guidelines
developed specifically for the study.
The reliability of the RoB tool has not been investigated by
comparing ratings of an external blinded panel of reviewers with
those obtained from authors of Cochrane reviews. This work is of
crucial importance for researchers who incorporate risk of bias
assessments from Cochrane- and non-Cochrane systematic
reviews into meta-epidemiological research approaches, since risk
of bias assessments obtained by different research group can lead
to different results. Furthermore, the reliability of the RoB in the
context of physical therapy (PT) trials has not yet been evaluated.
The objectives of this study were to test the inter-rater reliability of
the RoB tool applied to PT trials by comparing consensus ratings
from Cochrane review authors with those of blinded external
reviewers, and to investigate potential sources of disagreements to
inform the use of the RoB tool.
Methods
The Cochrane Database of Systematic Reviews (CDSR) was
systematically searched from 2005 to May 25 2011 for meta-
analyses of PT interventions using the words physical therapy,
physiotherapy, rehabilitation, exercise, electrophysical agents,
acupuncture, massage, transcutaneous electrical stimulation
(TENS), interferential current, ultrasound, stretching, chest
therapy, pulmonary rehabilitation, manipulative therapy, mobili-
zation, and related terms. For a detailed search strategy see
Appendix S1. Meta-analyses and their RCTs were included if: 1)
the meta-analysis included at least 5 RCTs, with at least one of the
interventions being currently or potentially part of PT practice
according to the World Confederation for Physical Therapy
(WCPT) [14]; 2) the outcome of interest in the meta-analysis
(explicitly described as the main outcome or the outcome with the
largest number of trials) was continuous; and 3) the RoB tool was
used for assessment of individual trials. A unique identifier was
assigned to meta-analyses and trials that met the inclusion criteria.
RoB assessments procedure
The risk of bias of individual trials included in the meta-analyses
was assessed on 6 domains (7 items) of the RoB tool [15]: sequence
generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessors, incomplete outcome
data, selective outcome reporting, and other sources of bias. We
followed the guidelines established by the Cochrane Collaboration
to perform RoB assessments; however we developed specific
decision rules to make decisions (Appendix S2). Risk of bias
evaluations for blinding and incomplete outcome data were based
upon the primary (continuous) outcome of interest selected for
meta-analysis in the Cochrane review. If not clearly specified, the
outcome was chosen according to the meta-analysis that contained
the largest number of trials in the review. The Cochrane guidelines
recommend using trial protocols to complete assessments of
selective outcome reporting bias. However, due to the low
likelihood of locating protocols for trials, we did not search for
study protocols [24]. Therefore, for the category of ‘‘low’’ risk of
bias, it was required that trial publications reported all primary
and secondary outcomes in the methods and results sections, with
new outcomes not being added in the results section. If the
primary outcome of the trial was not included in the results, there
was a high risk of selective outcome reporting bias. In addition we
paired outcomes reported in methods and results sections. If more
than 70% of the secondary outcomes were not reported in the
results or methods sections, then the study was rated as high RoB.
For ‘other bias’, we looked at baseline comparability, control for
co-interventions (contamination bias) and whether treatment
compliance was acceptable. These criteria have been used in the
risk of bias assessments of the Cochrane Back Review Group to
determine other sources of potential bias [16].
For the overall assessment of RoB, a trial was considered at low
risk of bias if it was rated as low risk in all individual domains; if
the rating was unclear in at least one domain, and the other
domains were unclear or low, the overall assessment of RoB was
unclear. Finally, an overall assessment of high risk of bias was
considered if at least one domain was rated as high [12,13].
Two independent reviewers (any of these reviewers: SAO,
JF, HS, CH, AC, DP) blinded to the RoB ratings reported in the
Cochrane reviews assessed the risk of bias of all PT trials included
in the meta-analyses. Each pair of reviewers assessed risk
of bias in each study and disagreements were resolved
by discussion between reviewers until consensus was
reached. If consensus was not achieved, a final decision on RoB
assessments was reached after consultation with a third reviewer
(first author), although this was not necessary. Blinding of the
external panel of reviewers was achieved as follows: 1) reviewers
were not told the objective of this study; 2) they were not provided
with RoB assessments performed by Cochrane reviewers; 3) after
the external panel of reviewers completed their assessments, an
independent reviewer who was not part of the review panel
extracted RoB data assessment performed by Cochrane reviewers
(MO). The integrity of blinding was assessed by asking the
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reviewers post hoc if they had checked the Cochrane RoB
assessment. None of them reported that they did.
Data on RoB assessments from Cochrane reviews and other
characteristics of reviews and trials were extracted by one reviewer
(MO or SAO) and entered directly into a pilot tested electronic
form. Consensus assessments between the two reviewers from
our panel were then compared with the RoB ratings from the
Cochrane reviews. In addition, two reviewers independently
assessed the RoB at the meta-analysis level for both groups of
reviewers (i.e. external panel of reviewers and Cochrane reviewers)
using the guidelines established by the Cochrane handbook
[15,17]. A low, unclear and high RoB at the meta-analysis level
was defined as: ‘‘most information is from studies at low, unclear
or high risk of bias respectively’’ [15,17]. Since no further
guidance is in the Cochrane handbook, we established an arbitrary
cut-off value of 60% to define the ‘‘majority of studies’’.
Assessments were compared and discrepancies were resolved by
consensus between reviewers.
Characteristics of the reviewers’ panel
Six reviewers with experience in different areas of health
sciences research comprised the review panel in this study. Two
reviewers had a Bachelor in Health Sciences (CH, AC), one had a
Masters in Public Health (DP), one had a Masters in Dentistry
and currently working on a PhD in Orthodontics (HS), and two
were physical therapists and had Masters and PhD in Rehabil-
itation sciences (SAO, JF) with at least 10 years of experience in
critical appraisal and systematic reviews. Four of them (DP, HS,
SAO, and JF), had formal training in critical appraisal and
systematic reviews. The other 2 (CH, AC) had at least one year of
hands-on experience conducting systematic reviews. Four of the
reviewers (SAO, JF, HS, CH) were part of the research
team collaborating in this project and two of them (DP,
AC) were hired to perform the data extraction and
quality assessments. All of them verbally agreed to
participate as reviewers in this study.
Training process
All reviewers were trained and received guidelines for RoB
assessments from the first author (SAO) who was a physical
therapist by training and had a MSc and PhD in Rehabilitation
Sciences and more than 10 years of experience in critical appraisal
and systematic reviews. Reviewer training was carried out using 10
trials not included in the study. Results of RoB assessments for
these 10 studies were independently reviewed and discussed in a
group meeting to determine consistency in ratings. In addition, the
team members met on a regular basis to further calibrate RoB
assessments throughout the study.
Statistical analysis
Inter-rater reliability of RoB assessments between Cochrane
and blinded external reviewers [18–20] and within the panel of
external reviewers was assessed using weighted kappa (k) for
categorical data. Inter-rater scores for both individual domains
and overall assessments of the RoB tool were considered. Analyses
were conducted using STATA (version 12, Stata Corp; College
Station, Texas; USA). For raw data for each domain see
Appendix S3.
Criteria proposed by Byrt [21] were used to interpret kappa
values. Values between 0.93–1.00 represented excellent agree-
ment; 0.81–0.92 very good agreement; 0.61–0.80 good agreement;
0.41–0.60 fair agreement; 0.21–0.40 slight agreement, 0.01–0.20
poor agreement; and 0.00 or less were considered to have no
agreement.
Results
Literature search
The systematic search of the CDSR resulted in the identification
of 3901 Cochrane review titles, with 271 reviews being potentially
relevant to physical therapy. Of these, 68 Cochrane reviews
included a meta-analysis of at least five studies on PT interventions
assessing a continuous outcome. Figure 1 outlines the retrieval of
Cochrane reviews and the number of trials included in the
analysis. A total of 109 trials included in 17 Cochrane reviews that
used the RoB tool were assessed. Table 1 summarizes the
characteristics of the Cochrane reviews included in the study.
Characteristics of selected studies
Briefly, the reviews were published between 2008 and 2011 and
included meta-analyses of the effectiveness of PT interventions for
musculoskeletal (9 reviews [22–30] cardiorespiratory (4 reviews)
[31–34], neurological (2 reviews) [35,36], gynaecological (1 review)
[37], and general conditions (1 review) [38].
The majority of Cochrane reviews (15 reviews) did not include a
formal evaluation of the inter-rater reliability of the RoB
assessments. Although the majority of reviews stated that two
independent reviewers assessed study RoB, in four reviews, a single
reviewer assessed RoB, with verification by a second reviewer.
Similarly, twelve of the 17 (71%) Cochrane systematic reviews did
not clearly specify the outcome used for the RoB assessments,
whereas eight out of 17 (47%) of systematic reviews combined all
outcomes into a single bias assessment.
A median number of six trials were included in the meta-
analyses (interquartile range: 5, 8). All but one cross-over trial were
identified as parallel trials. The majority of trials (n = 93) used
active controls whereas 15 trials were placebo-controlled. The
control group of one trial was not clearly identified. Seventy-five
trials were efficacy trials; 26 effectiveness trials, and seven trials
combined an evaluation of the efficacy/effectiveness of PT
interventions. One trial was not clearly described as an efficacy
or effectiveness trial.
The number of trials available for assessing the inter-rater
reliability of both individual-domain and overall RoB assessments
varied as not all Cochrane reviews reported ratings for all the
domains of the RoB tool. Inter-rater reliability of RoB assessments
between Cochrane review authors and blinded external reviewers
and the inter-rater reliability within the external panel of reviewers
are presented in Table 2.
Inter-rater agreement: Cochrane review authors vs.
blinded external reviewers
Inter-rater reliability on the overall RoB assessment between
Cochrane review authors and blinded external reviewers was poor
(k = 0.02, 95%CI: 20.06, 0.06). Inter-rater reliability on
individual domains of the RoB tool was poor (median k =0.19),
ranging from k = 20.04 (‘‘Other bias’’) to k = 0.62 (‘‘Sequence
generation’’). Table 2 displays the inter-rater reliability of the RoB
tool between the blinded external review panel versus Cochrane
reviewers.
When overall RoB categories assigned by blinded external
reviewers were compared to those of Cochrane review authors, we
found that the number of trials assessed as ‘‘low’’ risk of bias by
Cochrane review authors (n = 9) was greater than blinded
external reviewers (n = 3). Similarly, the number of trials rated as
‘‘high’’ risk of bias by Cochrane review authors (n = 66) was
greater than blinded external reviewers (n = 31). In contrast,
blinded external reviewers had a greater number of trials assessed
as ‘‘unclear’’ in the overall RoB assessment (n = 74) compared to
Poor Reliability of Risk of Bias in Physical Therapy
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Cochrane review authors (n = 33). The main source of
disagreement between Cochrane review authors and blinded
external reviewers in the overall rating of RoB was due to
discrepancies in the classification of ‘‘unclear’’ vs. ‘‘high’’ risk of
bias; with 45 trials rated as ‘‘high’’ risk of bias by Cochrane review
authors and ‘‘unclear’’ by blinded external reviewers.
Inter-rater agreement within the panel of blinded
external reviewers
The inter-rater reliability between blinded external reviewers on
the overall RoB rating was fair (k = 0.55, 95%CI: 0.40, 0.70).
Inter-rater reliability on individual domains of the RoB tool was
fair (median k =0.56) ranging from k = 0.32 (‘‘Other bias’’) to k
= 0.79 (‘‘allocation concealment’’).
Overall RoB at the Meta-analysis level
There was no agreement (k = 20.29, 95%CI: 20.81, 0.35) in
the overall RoB assessment at the meta-analysis level between
Cochrane review authors and blinded external reviewers.
Cochrane reviewers had evaluated 10 meta-analyses as high
RoB while the external panel of reviewers classified them as
‘‘unclear’’. Table 3 displays the RoB assessment at the meta-
analysis level.
Discussion
Based on the assessment of RCTs included in Cochrane reviews
of PT interventions, this study found that the inter-rater reliability
of RoB assessments between Cochrane review authors and blinded
external reviewers was poor. This result confirms the findings of
previous studies regarding the poor reliability of the RoB tool
domains in other areas of health research [9,10,12,13]. Our results
indicated that RoB assessments in Cochrane reviews could not be
replicated consistently by an external panel of reviewers using
consensus RoB assessments.
Consensus ratings are of crucial importance since they are
commonly used in systematic reviews. Only one previous study
assessed the reliability of the RoB based on consensus assessments
across pairs of reviewers from four research centres using a sample
of 30 trials indexed in PubMed between 2000 and 2006 [13].
Using a larger number of trials in PT and comparing the RoB
consensus ratings between blinded external reviewers and
Cochrane reviewers, our study confirmed that agreement across
pairs of reviewers is generally lower than agreement between
reviewers. Cochrane reviews have long been considered the gold
standard for systematic reviews in health care. Results of our study
have important implications for the interpretation of results of
RoB assessments across Cochrane reviews and produced by
different Cochrane Review Groups. The poor agreement in RoB
assessments between Cochrane reviewers and an external panel of
reviewers has raised several concerns: 1) RoB assessments cannot
be reproduced by different groups of reviewers. If true, it would
mean that RoB assessments are not reliable and depend on the
reviewers’ level of knowledge and familiarity with the information
provided in the individual trials; 2) the RoB tool is a very
subjective tool that cannot provide reliable assessments; 3) despite
efforts by the Cochrane Collaboration to establish high quality
standards for conducting systematic reviews, poor agreement
appears to be the norm rather than the exception when
conducting RoB assessments. Thus, we pose the following
questions: can we trust risk of bias results reported in Cochrane
reviews? Can we trust assessments using the RoB tool?
The low reliability of RoB assessments between our panel of
blinded external reviewers and Cochrane reviewers has implica-
tions for researchers who use bias ratings from Cochrane reviews
or other external sources to conduct meta-epidemiological
research on the relationship between trial characteristics and over
Figure 1. Diagram for the identification of reviews.
doi:10.1371/journal.pone.0096920.g001
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and under-estimation of treatment effects, since bias ratings
obtained by different research group can lead to different results.
For example, authors of meta-epidemiological studies [8,39,40],
have taken information from external sources (Cochrane assess-
ments, or information provided by authors of reviews). Although
using data reported in the reviews, it is a practical and cost-
efficient way to obtain information, authors should be aware that
these evaluations may be inconsistent and prone to bias due to
many factors such as expertise, training, level of education, and
other characteristics of reviewers making quality judgements.
Very low agreements among Cochrane reviewers and the
external panel were obtained for allocation concealment, blinding
of participants, blinding of outcome assessment, and incomplete
data. These features of a trial can have a substantial impact on the
estimates of treatment effect [5,9,40–42]. Some studies, for
example, have found that inadequate allocation concealment
or lack of double-blinding can overestimate treatment effects on
average by 18% and 9%, respectively [5,40,42]. Nevertheless,
other studies have found that trials with adequate
allocation concealment and blinding had higher treat-
ment effects than trials that did not accomplish with
these methodological features. [43,44] Similarly, effect sizes
from trials that excluded dropouts in the analysis or considered a
modified intention to treat (ITT) approach were more likely to
show a beneficial effect than trials without exclusions, demon-
strating that the ITT principle is important to preserve the benefits
of randomization and keep unbiased estimates [45–47]. Over-
estimates of treatment effects, or bias, at the trial level, can lead to
biased or inaccurate results and conclusions in systematic reviews
and meta-analyses [40,41,48–50]. In addition, our analyses
showed no agreement between decisions made based on RoB
assessments at the level of meta-analysis. This means that both
groups of reviewers did not agree in the overall quality of the
evidence at the meta-analysis level. These factors can ultimately
have repercussions on decision-making and quality of patient care
since different assessments could lead to different decisions for
clinical practice. Therefore, is alarming that the disagreements
obtained between the two panels of reviewers are worse when it
matters most.
The selection of different outcomes for RoB assessments may
have influenced the poor agreement between Cochrane reviewers
and a panel of blinded external reviewers. The majority of
Cochrane reviews analyzed did not clearly specify the outcome
used for RoB assessments. This directly reduces reproducibility of
RoB assessment for outcome-dependent domains of the tool.
Cochrane reviewers should report RoB assessments separately for
each outcome analyzed, or at least for the main outcomes of the
review. Half of the systematic reviews included in this study
combined all outcomes into a single bias assessment and therefore,
it is uncertain for which outcome the RoB assessments were
applicable. Cochrane reviewers should clearly state which
outcomes were used to perform the RoB assessments, in order
to allow reproducibility and comparison.
The RoB has been extensively used by many Cochrane reviews,
albeit the information of the inter-rater reliability of RoB is rather
limited. To date, five studies [9,10,12,13,51] have investigated the
inter-rater reliability of the RoB. One of them [51] did not use the
generic RoB tool but a 12-item modified version of the tool
developed by the Cochrane Back Review Group. The four other
studies were conducted by the same group of researchers. When
our inter-rater reliability results for the RoB tool were compared to
those of other studies, most kappa values for the RoB domains
were similar, except for allocation concealment, incomplete data,
selective reporting, and overall rating of the RoB tool. Our kappa
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values were much higher than those reported in previous studies
(Table 4). We suggest a variety of reasons for these differences.
Although we used the Cochrane Handbook guidelines for RoB
assessments, we pre-defined specific decision rules to assess the
individual domains of the tool. For example, the item of allocation
concealment was scored low only when studies used central
allocation (including telephone, web-based and centre controlled
randomization) or when envelopes with three adequate safeguards
were used (sequentially numbered, opaque, and sealed envelopes).
If all three safeguards were not described, the item was scored as
‘‘unclear’’. In addition to the Cochrane guidelines, the RoB item
of incomplete data was rated ‘‘low’’ when intention to treat was
conducted and the drop-out rate was less than or equal to 20%.
When the drop-out rate was higher than 20%, the item was scored
as ‘‘high’’ risk of bias since there is evidence that drop-out rates
higher than 20% are likely to increase bias in treatment estimates
[52,53].
Similarly, we created a precise decision rule for the item of
selective reporting, and identified a clear cut off to determine low,
unclear and high RoB categories. It is likely that all of these
decision rules may have increased the inter-reliability between the
blinded external reviewers in the RoB assessments for these
domains.
Final ratings of the RoB tool based on the Cochrane reviewers
assessments indicated that almost 92% of trials included in the
reviews had either high or unclear RoB; a proportion that is
similar to those identified in other studies [10,13]. As expressed by
other researchers [13], the large number of trials classified as high
or unclear RoB casts doubts about the discrimination power of the
RoB tool to differentiate between studies with different levels of
risk of bias that can explain variability of treatments effects across
studies and inform accurately practice based on these assessments.
Thus, it is important to highlight that the overall
assessment of the RoB may not be useful to determine
quality of individual trials. We used the guidelines
established by the Cochrane handbook to determine
overall RoB. However, these criteria can be considered
arbitrary and may not be appropriate. In addition, the
items included in the RoB may be insufficient to represent the
construct of interest: ‘‘Risk of bias’’. Other items not considered in
this tool may need to be added to provide a more comprehensive
evaluation. Some scales commonly used to evaluate the quality of
research (e.g. the Jadad scale) use only a limited number of items
(3) and have been criticized for their inability to distinguish among
good and bad quality studies [54]. This may be a similar problem
for the RoB, which may not include all important factors to
evaluate the full construct of ‘‘risk of bias’’. Empirical evidence
supports the evaluation of randomization, allocation concealment
and blinding of clinical trials, all of which are included in the RoB
tool. While there is insufficient evidence to support other domains
being included, other methodological factors could be important
for evaluating RoB and could be considered for inclusion in the
RoB tool after careful empirical evidence testing.
It is recommended that RoB assessments are made by
multidisciplinary groups of reviewers, in which epidemiologists,
methodologists, and clinicians with expertise in the content area of
the review participate in the assessments. Our panel of reviewers
had different levels of expertise, with two reviewers having at least
10 years of expertise in performing quality assessments and two of
them with expertise in the area of the physical therapy. This might
explain in part our higher levels of reliability compared to other
studies.
When junior researchers are involved in RoB assessments, it is
crucial that training in concepts and guidelines for assessing study
bias is provided prior to the start of the review [4]. Training should
be intense and monitored in each stage of the review. Previous
studies have trained reviewers using an average of 5 trials per
study. In contrast, we used 10 studies for training purposes and
Table 3. Comparison of Overall ratings at the meta-analysis level between external panel and Cochrane reviewers.
Meta-Analysis Overall RoB meta-analysis level External Panel reviewers Overall RoB meta-analysis level Cochrane reviewers
Agreements
Orozco, 2008 unclear unclear
Sirtory, 2009 unclear unclear
Davies, 2010 unclear unclear
Disagreements
States, 2009 unclear high
Fransen, 2009 high low
Handoll, 2009 high unclear
Effing, 2009 high unclear
Taylor, 2010 unclear high
Harvey, 2010 unclear high
Rutjes, 2010 unclear high
Katalinic, 2010 unclear high
Puhan, 2010 high high
Kramer, 2010 unclear high
Rutjes, 2010b unclear high
Manheimer, 2010 unclear high
Ostelo, 2011 unclear high
Schaafsma, 2011 unclear high
doi:10.1371/journal.pone.0096920.t003
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held regular meetings to discuss bias ratings of common papers.
These factors may have helped to obtain acceptable levels of
reliability between the external reviewer panel for most of the
domains of the RoB tool.
Limitations
This study restricted the analysis to a limited number of
Cochrane systematic reviews in PT and therefore, the results
might not reflect the inter-rater agreement of the RoB tool when
applied to Cochrane reviews conducted in other areas of research,
or to systematic reviews conducted out of the Cochrane
Collaboration. Future studies should further assess potential
differences in the inter-rater reliability of the RoB tool by
comparing bias ratings of Cochrane reviews and non-Cochrane
reviews versus those of independent panels of reviewers.
Future directions
The reliability of RoB assessments applied to clinical trials in
systematic reviews needs to be improved. The creation of an
international database (a bias assessment bank) in which a
qualified panel of experts (with extensive years of experience in
trial methodology and critical appraisal of the scientific literature)
contribute with independent RoB assessments of RCTs in a
variety of clinical areas would be a promising step in that direction.
Thus, researchers conducting systematic reviews and meta-
epidemiological studies can use this data bank as a gold standard
resource for RoB assessments. It is imperative that if an RoB
assessment bank is created, contributors have the proper
qualifications and experience to obtain less biased RoB assess-
ments.
Conclusions
As far of our knowledge, this study is the first to demonstrate
that risk of bias assessments of RCTs using the RoB tool are not
consistent across different research groups contrasting results from
Cochrane reviewers with an independent external panel of
reviewers. Poor agreement was not only demonstrated at the trial
level but also at the meta-analysis level. These results have
important implications for decision making since different
recommendations can be reached depending on the group
Table 4. Inter-rater reliability (kappa values) of the RoB tool reported in the scientific literature.
RoB Domains Current Study
Hartling et al.,
2011 [13]
Hartling
et al., 2012 [14]
Hartling et al.,
2009 [9] Graham et al., 2012 [50]
Sequence generation 0.71 0.86 0.79 0.74 0.66
Allocation concealment 0.79 0.54 0.24 0.5 0.76
Blinding of participants
and personnel
0.56 0.62 0.33 0.35 0.64
Blinding outcome
assessment
0.54 0.62 0.33 0.35 0.5
Incomplete data 0.71 0.44 0.34 0.32 –
Selective reporting 0.50 0.40 0.27 0.13 –
Other bias 0.32 0.52 0.24 0.31 –
Overall rating 0.55 0.41 0.21 0.27 –
Assessment
characteristics
Type of trials PT trials Asthma trials General health Paediatric trials Cervical/rehab trials
Number of trials 109 107 154 163 18
Trial evaluation
specific to a single SR
No Yes No No NR
Number of trials used in
pilot/training phase
10 ?? 5 5 NR
Number of reviewers 6 ?? 12 5 NR
Reviewers expertise Physical therapy (2),
methodology (6), public
health (1), dentistry (1) and
health related sciences (2).
Doctorate (2), PhD
candidate (1), Master
level (1), undergraduate
level (2)
NR Doctorate (3); Master
degree in health (8),
epidemiology (1),
undergraduate (1)
NR Clinicians (physiotherapists,
chiropractors, physicians), and
statistician
Experience time
conducting quality
assessments
4 months – 10 years NR 2–10 years NR 5–50 years
Reviewers with formal
training in SRs
3 NR 10 NR NR
Outcomes used for RoB
evaluation
Different outcome
measures
Very specific
outcomes
Different outcome
measures
Different
outcome measures
NR
RoB = Risk of Bias; SR = systematic review.
doi:10.1371/journal.pone.0096920.t004
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analyzing the evidence. Improved guidelines to apply the RoB tool
and revisions to the tool for different health areas are needed. In
addition, empirical evidence supporting additional items for the
RoB tool needs to be developed. A call is made for the creation of
a bank of RoB assessments of trial data, maintained by
methodological and clinical experts that can be used as a reliable
gold standard resource for RoB assessments. (4453 Words)
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